Essling Expansion, the private equity fund specialized in small and medium capitalization of Essling Capital, invests 16 million euros to enter Evolucare’s capital. This operation is combined with a financial debt of 10 million euros. This should provide this SME with the means to « accelerate its development » as the President Elie Le Guilcher comments, by strengthening its research as well as its international strategy.
At CES 2019, Evolucare, associated with ADCIS, enters into a global and exclusive license agreement with SATT Ouest Valorisation, a French technology transfer office, and AP-HP Paris hospitals for the exploitation of OphtAI
Evolucare has signed a partnership agreement with GTD Intesis so as to extend its operations and activities towards Latin America. GTD Intesis is a Chilean market leader in IT integration…
Intrasense, specialist in medical imaging software solutions and Evolucare, announce the signature of a multi-year strategic partnership agreement.
